Revive Therapeutics Ltd (RVVTF)

[MrNormall]

Revive Therapeutics Ltd. currently Enrolling for Phase 3 Trial for Bucillamine in Treatment of Patients With COVID-19

https://clinicaltrials.gov/ct2/show/NCT04504734?term=NCT04504734&draw=2&rank=1

Study Type : Interventional (Clinical Trial)
Estimated Enrollment : 1000 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Masking Description: Double-blind, placebo controlled
Primary Purpose: Treatment
Official Title: Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of Bucillamine in Patients With Mild-Moderate COVID-19

$RVVTF